Racial and Ethnic Disparities in Cancer-Associated Thrombosis

Active malignancy increases the risk of developing venous thromboembolism (VTE) by four- to seven-fold. The risk of VTE, including deep vein thrombosis and pulmonary embolism, in patients with cancer varies based on several clinical factors, such as cancer stage and age. However, race and ethnicity are also associated with increased VTE risk. Black (African American) patients with cancer have a higher risk of developing VTE than White patients, while Asian/Pacific Islanders have a lower risk. Studies on cancer-associated thrombosis demonstrate a need to advance our understanding of both the biologic and sociologic underpinnings of the observed differences according to race. Addressing the causes of these disparities can better health outcomes for historically underserved patient populations.

Automated summary

Active malignancy increases the risk of developing venous thromboembolism (VTE) by four- to seven-fold. Race and ethnicity play a role in VTE risk, with black patients having a higher risk and Asian/Pacific Islanders having a lower risk. Understanding the biological and sociological factors behind these disparities can lead to better health outcomes for underserved populations.